Bayer is finally launching Precose (acarbose)

January 1996

Bayer is finally launching Precose (acarbose)...a novel drug for type II, or non-insulin-dependent, diabetes.

Precose is an alpha-glucosidase inhibitor. Blocking this enzyme in the intestine slows the breakdown of carbohydrates to glucose. This reduces hyperglycemia...especially after meals.

You can use Precose alone...or with other antidiabetic meds.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

more about using thrombolytics for acute ischemic strokes
Diabetes Bayer is finally launching Precose (acarbose)
Cardiology the recent concerns about calcium blockers decreasing survival
Cardiology new calcium channel blocker for hypertension called Sular (nisoldipine)
Oral Health some people get fewer canker sores when they switch to a toothpaste that doesn't contain sodium lauryl sulfate (SLS)
Oral Health Trental (pentoxifylline) for severe cases of recurrent canker sores
Cholesterol one cholesterol test isn't enough to diagnose a patient with hyperlipidemia
approving the antihistamine clemastine (Tavist) for cold symptoms
Hematology & Oncology limit tamoxifen (Nolvadex) use to 5 years
Hematology & Oncology Vesanoid, the first vitamin A derivative that's been approved for treating cancer
Anticoagulants ReoPro (abciximab) to inhibit blood clotting
Ritalin (methylphenidate) for ADHD
Avonex (interferon beta-1a) for multiple sclerosis
using two nicotine patches a day

Bayer is finally launching Precose (acarbose)

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents